Concepedia

K. Passarge

KP

3

Publications

276

Citations

3

H-Index

2004

Active since

Affiliations

University Hospitals of the Ruhr-University of Bochum(Current)

West German Heart and Vascular Center Essen

Bayer (United States)

Bayer (Germany)

K. Passarge is an author at University Hospitals of the Ruhr-University of Bochum specializing in oncology, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

2004–2006

3

Publications

3

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

Heike Richly, Bernhard F. Henning, P. Kupsch et al. · Annals of Oncology · 2006 · 142 citations · Full text

, , +8

Results of a Phase I Trial of Sorafenib (BAY 43-9006) in Combination with Oxaliplatin in Patients with Refractory Solid Tumors, Including Colorectal Cancer

P. Kupsch, Bernhard F. Henning, K. Passarge et al. · Clinical Colorectal Cancer · 2005 · 114 citations

, , +9

Results of a phase I trial of BAY 43–9006 in combination with doxorubicin in patients with refractory solid tumors

Heike Richly, P. Kupsch, K. Passarge et al. · Journal of Clinical Oncology · 2004 · 20 citations

, , +18

Rows per page

1–3 of 3